<!DOCTYPE html>
<html lang="en" dir="auto">

<head><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>OrgSyn046 | OrgSyn</title>
<meta name="keywords" content="">
<meta name="description" content="本文策略为光催化 [2&#43;2] 氮杂双环合成。原文：Org. Synth.  2024 ,  101 , 410-422.">
<meta name="author" content="Argon">
<link rel="canonical" href="/posts/orgsyn046/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.css" rel="preload stylesheet" as="style">
<link rel="icon" href="/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
<link rel="apple-touch-icon" href="/apple-touch-icon.png">
<link rel="mask-icon" href="/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" hreflang="en" href="/posts/orgsyn046/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:url" content="/posts/orgsyn046/">
  <meta property="og:site_name" content="OrgSyn">
  <meta property="og:title" content="OrgSyn046">
  <meta property="og:description" content="本文策略为光催化 [2&#43;2] 氮杂双环合成。原文：Org. Synth. 2024 , 101 , 410-422.">
  <meta property="og:locale" content="en">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-04-07T13:20:21+08:00">
    <meta property="article:modified_time" content="2025-04-07T13:20:21+08:00">
      <meta property="og:image" content="/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:image" content="/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E">
<meta name="twitter:title" content="OrgSyn046">
<meta name="twitter:description" content="本文策略为光催化 [2&#43;2] 氮杂双环合成。原文：Org. Synth.  2024 ,  101 , 410-422.">


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position":  1 ,
      "name": "Posts",
      "item": "/posts/"
    }
    {
      "@type": "ListItem",
      "position":  1 ,
      "name": "OrgSyn046",
      "item": "/posts/orgsyn046/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "OrgSyn046",
  "name": "OrgSyn046",
  "description": "本文策略为光催化 [2+2] 氮杂双环合成。原文：Org. Synth. 2024 , 101 , 410-422.\n",
  "keywords": [
    
  ],
  "articleBody": "本文策略为光催化 [2+2] 氮杂双环合成。原文：Org. Synth. 2024 , 101 , 410-422.\n简述 反应使用二烯丙基胺，在 5mol% CuSO4·5H2O 催化下，用254nm光照射发生 [2+2] 环加成，构建双环并环。\n讨论 含氮杂环在药物化学中非常重要，60%的药物结构中都有它的身影1，哌啶和吡啶分别是第一和第五常见的杂环结构，可见其常见和重要程度。\n它们的同系物也经常引起人们兴趣，例如 3-azabicyclo[3.1.0]hexane 和 3-azabicyclo[3.3.0]octane，可以作为多种生物分子的合成骨架2。然而，3-azabicylo[3.2.0]heptane 却少见报导，它可以用作 belaperidone 和 ecenofloxacin 等药物分子的骨架，但是难以合成，因此限制了其应用。\n关于 3-azabicylo[3.2.0]heptane 的相关合成基本都通过电化学方法实现3，往往会包含许多不想要的副产物，且很难除去。\nKochi-Salomon 反应是目前唯一已知的由未活化烯烃参与的光催化 [2+2] 环加成4，但是其缺点在于对胺不耐受，因此想通过该反应合成含氮杂环双环化合物并不可行。\n最近作者团队的研究改变了这一现状，设计了能够耐受胺的 Kochi-Salomon 反应改进版，使用常见的 Cu(Ⅱ) 盐在水中进行反应，大大提高了该反应的适用性。\n通过该反应可以合成 3-azabicylo[3.2.0]heptane，尽管产率较低（分离难度较高），但是相对于其高昂的售价（$ 1,540.50/g），仍不失为一种快速且经济的合成策略。\n参考 Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014, 57, 10257-10274. DOI: 10.1021/jm501100b. ↩︎\n(a) Patel, S.; Meilandt, W. J.; Erickson, R. I.; Chen, J.; Deshmukh, G.; Estrada, A. A.; Fuji, R. N.; Gibbons, P.; Gustafson, A.; Harris, S. F.; Imperio, J.; Liu, W.; Liu, X.; Liu, Y.; Lyssikatos, J. P.; Ma, C.; Yin, J.; Lewcock, J. W.; Siu, M. Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease. J. Med. Chem. 2017, 60, 8083-8102. DOI: 10.1021/acs.jmedchem.7b00843; (b) Zhu, C.; Kar, N. F.; Li, B.; Costa, M.; Dingley, K. H.; Di Salvo, J.; Ha, S. N.; Hurley, A. L.; Li, X.; Miller, R. R.; Salituro, G. M.; Struthers, M.; Weber, A. E.; Hale, J. J.; Edmondson, S. D. Discovery of benzamides as potent human β3 adrenergic receptor agonists. Bioorg. Med. Chem. Lett. 2016, 26, 55-59. DOI: 10.1016/j.bmcl.2015.11.030; (c) Futatsugi, K.; Smith, A. C.; Tu, M.; Raymer, B.; Ahn, K.; Coffey, S. B.; Dowling, M. S.; Fernando, D. P.; Gutierrez, J. A.; Huard, K.; Jasti, J.; Kalgutkar, A. S.; Knafels, J. D.; Pandit, J.; Parris, K. D.; Perez, S.; Pfefferkorn, J. A.; Price, D. A.; Ryder, T.; Shavnya, A.; Stock, I. A.; Tsai, A. S.; Tesz, G. J.; Thuma, B. A.; Weng, Y.; Wisniewska, H. M.; Xing, G.; Zhou, J.; Magee, T. V. Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. J. Med. Chem. 2020, 63, 13546-13560. DOI: 10.1021/acs.jmedchem.0c00944; (d) Cioffi, C. L.; Dobri, N.; Freeman, E. E.; Conlon, M. P.; Chen, P.; Stafford, D. G.; Schwarz, D. M. C.; Golden, K. C.; Zhu, L.; Kitchen, D. B.; Barnes, K. D.; Racz, B.; Qin, Q.; Michelotti, E.; Cywin, C. L.; Martin, W. H.; Pearson, P. G.; Johnson, G.; Petrukhin, K. Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease. J. Med. Chem. 2014, 57, 7731-7757. DOI: 10.1021/jm5010013; (e) For selected FDA approved medications, see: gliclazide, telaprevir, boceprevir, trovafloxacin. ↩︎\n(a) Poplata, S.; Tröster, A.; Zou, Y.-Q.; Bach, T. Recent Advances in the Synthesis of Cyclobutanes by Olefin [2+2] Photocycloaddition Reactions. Chem. Rev. 2016, 116, 9748-9815. DOI: 10.1021/acs.chemrev.5b00723; (b) Crimmins, M. T.; Reinhold, T. L. Enone Olefin [2 + 2] Photochemical Cycloadditions. Org. React. 2004, 44, 297-588. DOI: 10.1002/0471264180.or044.02. ↩︎\n(a) Salomon, R. G.; Kochi, J. K. Copper(I) Catalysis in Photocycloadditions. I. Norbornene. J. Am. Chem. Soc. 1974, 96, 1137-1144. DOI: 10.1021/ja00811a030; (b) Salomon, R. G.; Folting, K.; Streib, W. E.; Kochi, J. K. Copper(I) Catalysis in Photocycloadditions. II. Cyclopentene, Cyclohexene, and Cycloheptene. J. Am. Chem. Soc. 1974, 96, 1145-1152. DOI: 10.1021/ja00811a031; (c) Salomon, R. G.; Coughlin, D. J.; Ghosh, S.; Zagorski, M. G. Copper(I) Catalysis of Olefin Photoreactions. 9. Photobicyclization of α-, β-, and γ-Alkenylallyl Alcohols. J. Am. Chem. Soc. 1982, 104, 998-1007. DOI: 10.1021/ja00368a014; (d) Ghosh, S.; Raychaudhuri, S. R.; Salomon, R. G. Copper(I) Catalysis of Olefin Photoreactions. 15. Synthesis of Cyclobutanated Butyrolactones via Copper(I)-Catalyzed Intermolecular Photocycloadditions of Homoallyl Vinyl or Diallyl Ethers. J. Org. Chem. 1987, 52, 83-90. DOI: 10.1021/jo00377a015; (e) Salomon, R. G.; Ghosh, S.; Raychaudhuri, S. R.; Miranti, T. S. Synthesis of Multicyclic Pyrrolidines via Copper(I) Catalyzed Photobicyclization of Ethyl N,N-Diallyl carbamates. Tetrahedron Lett. 1984, 25, 3167-3170. DOI: 10.1016/S0040-4039(01)90999-2; (f) Gravatt, C. S.; Melecio-Zambrano, L.; Yoon, T. P. Olefin-Supported Cationic Copper Catalysts for Photochemical Synthesis of Structurally Complex Cyclobutanes. Angew. Chem., Int. Ed. 2021, 60, 3989-3993. DOI: 10.1002/anie.202013067. ↩︎\n",
  "wordCount" : "636",
  "inLanguage": "en",
  "image": "/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E","datePublished": "2025-04-07T13:20:21+08:00",
  "dateModified": "2025-04-07T13:20:21+08:00",
  "author":{
    "@type": "Person",
    "name": "Argon"
  },
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "/posts/orgsyn046/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "OrgSyn",
    "logo": {
      "@type": "ImageObject",
      "url": "/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="/" accesskey="h" title="OrgSyn (Alt + H)">
                <img src="/apple-touch-icon.png" alt="" aria-label="logo"
                    height="35">OrgSyn</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="/archives/" title="archive">
                    <span>archive</span>
                </a>
            </li>
            <li>
                <a href="/about/" title="about">
                    <span>about</span>
                </a>
            </li>
            <li>
                <a href="/search/" title="search (Alt &#43; /)" accesskey=/>
                    <span>search</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main">

<article class="post-single">
  <header class="post-header">
    <div class="breadcrumbs"><a href="/">Home</a>&nbsp;»&nbsp;<a href="/posts/">Posts</a></div>
    <h1 class="post-title entry-hint-parent">
      OrgSyn046
    </h1>
    <div class="post-meta"><span title='2025-04-07 13:20:21 +0800 CST'>April 7, 2025</span>&nbsp;·&nbsp;3 min&nbsp;·&nbsp;636 words&nbsp;·&nbsp;Argon&nbsp;|&nbsp;<a href="https://github.com/%3cpath_to_repo%3e/content" rel="noopener noreferrer" target="_blank">Suggest Changes</a>

</div>
  </header> <div class="toc">
    <details >
        <summary accesskey="c" title="(Alt + C)">
            <span class="details">Table of Contents</span>
        </summary>

        <div class="inner"><nav id="TableOfContents">
  <ul>
    <li><a href="#简述">简述</a></li>
    <li><a href="#讨论">讨论</a></li>
    <li><a href="#参考">参考</a></li>
  </ul>
</nav>
        </div>
    </details>
</div>

  <div class="post-content"><p>本文策略为光催化 [2+2] 氮杂双环合成。原文：<em>Org. Synth.</em>  <strong>2024</strong> ,  <em>101</em> , 410-422.</p>
<h2 id="简述">简述<a hidden class="anchor" aria-hidden="true" href="#简述">#</a></h2>
<p><img alt="046-1" loading="lazy" src="https://img.z4a.net/images/2025/04/07/046-1.png"></p>
<p>反应使用二烯丙基胺，在 5mol% CuSO4·5H2O 催化下，用254nm光照射发生 [2+2] 环加成，构建双环并环。</p>
<h2 id="讨论">讨论<a hidden class="anchor" aria-hidden="true" href="#讨论">#</a></h2>
<p>含氮杂环在药物化学中非常重要，60%的药物结构中都有它的身影<sup id="fnref:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup>，哌啶和吡啶分别是第一和第五常见的杂环结构，可见其常见和重要程度。</p>
<p>它们的同系物也经常引起人们兴趣，例如 3-azabicyclo[3.1.0]hexane 和 3-azabicyclo[3.3.0]octane，可以作为多种生物分子的合成骨架<sup id="fnref:2"><a href="#fn:2" class="footnote-ref" role="doc-noteref">2</a></sup>。然而，3-azabicylo[3.2.0]heptane 却少见报导，它可以用作 belaperidone 和 ecenofloxacin 等药物分子的骨架，但是难以合成，因此限制了其应用。</p>
<p>关于 3-azabicylo[3.2.0]heptane 的相关合成基本都通过电化学方法实现<sup id="fnref:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>，往往会包含许多不想要的副产物，且很难除去。</p>
<p>Kochi-Salomon 反应是目前唯一已知的由未活化烯烃参与的光催化 [2+2] 环加成<sup id="fnref:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>，但是其缺点在于对胺不耐受，因此想通过该反应合成含氮杂环双环化合物并不可行。</p>
<p><img alt="046-2" loading="lazy" src="https://img.z4a.net/images/2025/04/07/046-2.png"></p>
<p>最近作者团队的研究改变了这一现状，设计了能够耐受胺的 Kochi-Salomon 反应改进版，使用常见的 Cu(Ⅱ) 盐在水中进行反应，大大提高了该反应的适用性。</p>
<p>通过该反应可以合成 3-azabicylo[3.2.0]heptane，尽管产率较低（分离难度较高），但是相对于其高昂的售价（$ 1,540.50/g），仍不失为一种快速且经济的合成策略。</p>
<h2 id="参考">参考<a hidden class="anchor" aria-hidden="true" href="#参考">#</a></h2>
<div class="footnotes" role="doc-endnotes">
<hr>
<ol>
<li id="fn:1">
<p>Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014, 57, 10257-10274. DOI: 10.1021/jm501100b.&#160;<a href="#fnref:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:2">
<p>(a) Patel, S.; Meilandt, W. J.; Erickson, R. I.; Chen, J.; Deshmukh, G.; Estrada, A. A.; Fuji, R. N.; Gibbons, P.; Gustafson, A.; Harris, S. F.; Imperio, J.; Liu, W.; Liu, X.; Liu, Y.; Lyssikatos, J. P.; Ma, C.; Yin, J.; Lewcock, J. W.; Siu, M. Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer&rsquo;s Disease. J. Med. Chem. 2017, 60, 8083-8102. DOI: 10.1021/acs.jmedchem.7b00843; (b) Zhu, C.; Kar, N. F.; Li, B.; Costa, M.; Dingley, K. H.; Di Salvo, J.; Ha, S. N.; Hurley, A. L.; Li, X.; Miller, R. R.; Salituro, G. M.; Struthers, M.; Weber, A. E.; Hale, J. J.; Edmondson, S. D. Discovery of benzamides as potent human β3 adrenergic receptor agonists. Bioorg. Med. Chem. Lett. 2016, 26, 55-59. DOI: 10.1016/j.bmcl.2015.11.030; (c) Futatsugi, K.; Smith, A. C.; Tu, M.; Raymer, B.; Ahn, K.; Coffey, S. B.; Dowling, M. S.; Fernando, D. P.; Gutierrez, J. A.; Huard, K.; Jasti, J.; Kalgutkar, A. S.; Knafels, J. D.; Pandit, J.; Parris, K. D.; Perez, S.; Pfefferkorn, J. A.; Price, D. A.; Ryder, T.; Shavnya, A.; Stock, I. A.; Tsai, A. S.; Tesz, G. J.; Thuma, B. A.; Weng, Y.; Wisniewska, H. M.; Xing, G.; Zhou, J.; Magee, T. V. Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. J. Med. Chem. 2020, 63, 13546-13560. DOI: 10.1021/acs.jmedchem.0c00944; (d) Cioffi, C. L.; Dobri, N.; Freeman, E. E.; Conlon, M. P.; Chen, P.; Stafford, D. G.; Schwarz, D. M. C.; Golden, K. C.; Zhu, L.; Kitchen, D. B.; Barnes, K. D.; Racz, B.; Qin, Q.; Michelotti, E.; Cywin, C. L.; Martin, W. H.; Pearson, P. G.; Johnson, G.; Petrukhin, K. Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease. J. Med. Chem. 2014, 57, 7731-7757. DOI: 10.1021/jm5010013; (e) For selected FDA approved medications, see: gliclazide, telaprevir, boceprevir, trovafloxacin.&#160;<a href="#fnref:2" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:3">
<p>(a) Poplata, S.; Tröster, A.; Zou, Y.-Q.; Bach, T. Recent Advances in the Synthesis of Cyclobutanes by Olefin [2+2] Photocycloaddition Reactions. Chem. Rev. 2016, 116, 9748-9815. DOI: 10.1021/acs.chemrev.5b00723; (b) Crimmins, M. T.; Reinhold, T. L. Enone Olefin [2 + 2] Photochemical Cycloadditions. Org. React. 2004, 44, 297-588. DOI: 10.1002/0471264180.or044.02.&#160;<a href="#fnref:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:4">
<p>(a) Salomon, R. G.; Kochi, J. K. Copper(I) Catalysis in Photocycloadditions. I. Norbornene. J. Am. Chem. Soc. 1974, 96, 1137-1144. DOI: 10.1021/ja00811a030; (b) Salomon, R. G.; Folting, K.; Streib, W. E.; Kochi, J. K. Copper(I) Catalysis in Photocycloadditions. II. Cyclopentene, Cyclohexene, and Cycloheptene. J. Am. Chem. Soc. 1974, 96, 1145-1152. DOI: 10.1021/ja00811a031; (c) Salomon, R. G.; Coughlin, D. J.; Ghosh, S.; Zagorski, M. G. Copper(I) Catalysis of Olefin Photoreactions. 9. Photobicyclization of α-, β-, and γ-Alkenylallyl Alcohols. J. Am. Chem. Soc. 1982, 104, 998-1007. DOI: 10.1021/ja00368a014; (d) Ghosh, S.; Raychaudhuri, S. R.; Salomon, R. G. Copper(I) Catalysis of Olefin Photoreactions. 15. Synthesis of Cyclobutanated Butyrolactones via Copper(I)-Catalyzed Intermolecular Photocycloadditions of Homoallyl Vinyl or Diallyl Ethers. J. Org. Chem. 1987, 52, 83-90. DOI: 10.1021/jo00377a015; (e) Salomon, R. G.; Ghosh, S.; Raychaudhuri, S. R.; Miranti, T. S. Synthesis of Multicyclic Pyrrolidines via Copper(I) Catalyzed Photobicyclization of Ethyl N,N-Diallyl carbamates. Tetrahedron Lett. 1984, 25, 3167-3170. DOI: 10.1016/S0040-4039(01)90999-2; (f) Gravatt, C. S.; Melecio-Zambrano, L.; Yoon, T. P. Olefin-Supported Cationic Copper Catalysts for Photochemical Synthesis of Structurally Complex Cyclobutanes. Angew. Chem., Int. Ed. 2021, 60, 3989-3993. DOI: 10.1002/anie.202013067.&#160;<a href="#fnref:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
</ol>
</div>

  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
<nav class="paginav">
  <a class="prev" href="/posts/orgsyn047/">
    <span class="title">« Prev</span>
    <br>
    <span>OrgSyn047</span>
  </a>
  <a class="next" href="/posts/orgsyn045/">
    <span class="title">Next »</span>
    <br>
    <span>OrgSyn045</span>
  </a>
</nav>

  </footer>
</article>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="/">OrgSyn</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
